Armata Pharmaceuticals Q3 EPS $(0.15) Beats $(0.28) Estimate, Sales $2.97M Beat $900.00K Estimate

Author: Benzinga Newsdesk | November 13, 2024 05:31pm
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 82.56 percent increase over losses of $(0.86) per share from the same period last year. The company reported quarterly sales of $2.97 million which beat the analyst consensus estimate of $900.00 thousand by 230.33 percent. This is a 142.69 percent increase over sales of $1.23 million the same period last year.

Posted In: ARMP